Cardiac Imaging Software Market Outlook:
Cardiac Imaging Software Market size was valued at USD 675.86 million in 2024 and is expected to reach USD 1.5 billion by 2034, registering around 8.3% CAGR during the forecast period i.e., between 2025-2034. In the year 2025, the industry size of cardiac imaging software is assessed at USD 723.54 million.
Key Cardiac Imaging Software Market Insights Summary:
North America is projected to maintain its dominance in the cardiac imaging software market.
Asia Pacific is set to experience the highest CAGR in the cardiac imaging software market.
The tomography segment is likely to contribute notably to the revenue stream of the cardiac imaging software market.
The hospitals segment is forecasted to lead the cardiac imaging software market by the end of 2034.
Key Growth Trends:
- Continuous upgradation in pipelines
- Shifting consumer preference toward less-invasiveness
Key Players:
- Siemens Healthcare, Toshiba, GE Healthcare, Philips Healthcare, Epsilon Imaging, Shimadzu Corporation, Circle Cardiovascular Imaging Inc., CardioComm Solutions Inc., Integer Holdings Corporation, McKesson Corporation, Exo Healthcare.
Market Size and Growth Projections:
- 2024 Market Size: USD 675.86 million
- 2025 Market Size: USD 723.54 million
- Projected Market Size: USD 1.5 billion by 2034
- Growth Forecasts: 8.3% CAGR (2025-2034)
- Largest Region: North America (33.2% Share by 2034)
- Fastest Growing Region: North America
The increasing adoption of a sedentary lifestyle encompasses intermediate risk factors such as raised blood pressure, raised blood glucose, raised blood lipids, and obesity. These comorbidities are further diagnosed through imaging devices that help in the detection of a heart attack, stroke, heart failure, and other complications. Thus, the heightening impact of cardiovascular diseases (CVDs) is expected to drive demand in the market significantly. According to the World Heart Federation, this condition took over 20.5 million lives in 2021, accounting for almost 33.3% of total worldwide deaths. Further, the world is projected to witness 90.0%, 73.4%, and 54.7% increments in prevalence, crude mortality, and crude disability-adjusted life years (DALYs), respectively, between 2025 and 2050 (NLM).
Currently, growing incidences of cardiac arrests in the pediatric population are also expected to increase business flow in the cardiac imaging software market. To combat the widespread, many multi-national companies are now concentrating towards new product advances to pose a strong foothold over this merchandise. More technological innovations and affordable options are being introduced, which embark on continuous development and wide adoption. For instance, in February 2024, Royal Philips launched a cost-effective diagnostic system, Philips CT 5300, while providing more accurate and reliable imaging results, even in complex cardiac cases. This multifunctional tool is powered by exceptional AI capabilities streamlining workflow efficiency in diagnosis, interventions, and screenings.
Cardiac Imaging Software Market Growth Drivers and Challenges:
Growth Drivers
- Continuous upgradation in pipelines: On the back of advancements in cloud computing and generative AI that enable shortened exam times and improved imaging in compact design, the cardiac imaging software market is expected to grow robustly. The new generation software allows automatic and contemplated analysis of structural and functional change of the heart to help understand and predict future and present possibilities of developing life-threatening conditions. Additionally, ongoing R&D activities to make systems more user-friendly and affordable are anticipated to boost adoption and reach in this sector. For instance, in October 2024, TeraRecon extended the capabilities of its Intuition platform by adding a semi-automated cardiac MRI workflow.
- Shifting consumer preference toward less-invasiveness: As more patients seek shorter hospital stays and less blood loss, the emergence of minimally invasive solutions becomes more influential, stimulating growth in the cardiac imaging software market. The non-invasive diagnostic procedures such as MRI, CT scans, and echocardiograms align with this surge. On the other hand, the trend of digitalization in healthcare is empowering the penetration of cloud and AI in this category. Thus, these factors are conjugately contributing to the increased acceptance of this field in medical settings across the world. This can be testified by the dominance of the cardiac monitoring and diagnosis segment in the cardiovascular digital solutions industry by 2034.
Challenges
- Stringent compliance criteria: For global scale distribution, alignment with various regulatory body standards is essential. However, this becomes a tedious process due to the concerns about data breaching, limiting the growth of the cardiac imaging software market. Frameworks such as HIPPA and GDPR impose strict requirements for information protection to ensure privacy, which may result in additional expenses and delays in commercialization.
- Limitations in complete integration: The new-generation tools from the cardiac imaging software market require a skilled workforce for efficient operation and management. The complex data processing and configuration of these computer platforms often fail to showcase their full potential due to the shortage of trained operators. This may present difficulties for resource-constrained healthcare settings, particularly in underserved regions, in adopting them.
Cardiac Imaging Software Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2034 |
|
CAGR |
8.3% |
|
Base Year Market Size (2024) |
USD 675.86 million |
|
Forecast Year Market Size (2034) |
USD 1.5 billion |
|
Regional Scope |
|
Cardiac Imaging Software Market Segmentation:
Imaging Type Segment Analysis
Based on the imaging type, the tomography segment is expected to generate a significant revenue for the cardiac imaging software market over the assessed timeline. This segment is augmenting leadership with continuous technological advancements and a broad range of applications. A 2022 NLM review of randomized clinical trials on the use of cardiac computed tomography (CCT) revealed that it has the potential to decrease coronary artery disease (CAD) mortality by 41.0%. Besides, this method is also proven to be effective for preventing myocardial infraction and acute chest pain. It makes this sub-type a priority for global leaders, imposing greater business opportunities. Furthermore, the integration of AI and machine learning (ML) into these imaging systems is revolutionizing their efficiency in both clinical and research utilities.
End users Segment Analysis
In terms of end users, the hospitals segment is predicted to dominate the cardiac imaging software market by the end of 2034. The growing expenditure on these organizations for infrastructural development from both public and private investors is ensuring a stable cash flow in this sub-category. Being a primary point-of-care for patients, this segment is affiliated with several government subsidies, which attracts patients for attaining services. It also represents a large consumer base and lucrative scopes of investment for this sector. This can be testified by the 2021 report from Invest India, which highlighted a USD 32.0 billion worth of 582 investment opportunities in nationwide medical infrastructure. Similarly, IBEF reported that the hospital industry in India is projected to reach USD 193.5 billion by 2032.
Our in-depth analysis of the global cardiac imaging software market includes the following segments:
|
Imaging Type |
|
|
End users |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Cardiac Imaging Software Market Regional Analysis:
North American Market Insights
North America is anticipated to showcase dominance over the cardiac imaging software market throughout the analyzed period. The region has a well-developed healthcare approach and a wide network of efficient medical facilities, filling it with lucrative opportunities for global pioneers in this sector. The wide use of cloud-based modules for the management of data collected from diagnosis and clinical trials has established an accepting culture across various medical settings. Thus, the presence of MedTech leaders such as GE Healthcare and Abbott is empowering the penetration of AI in associated medical devices. On this note, Research Nester reported that North America is projected to hold the largest revenue share of 33.2% in the global cardiovascular digital solutions industry by 2034.
The growing obese population in the U.S. possesses a high risk of developing several cardiovascular events, necessitating the use of early detection tools. The obesity epidemic in this country demonstrated a prevalence of 40.3% among adult citizens during the timeline between 2021 and 2023 (CDC). Further, over 51.0% of the total population in the U.S. is projected to be obese by 2030, as per the American Journal of Preventive Medicine. These figures are evidence of the surging demand in this field. Moreover, the favorable regulatory framework and government initiatives are promoting nationwide adoption in the cardiac imaging software market. For instance, in April 2024, the FDA provided clearance for marketing Exo’s high-performance handheld ultrasound device, Exo Iris, with cardiac and lung AI applications.
APAC Market Insights
Asia Pacific is poised to augment the fastest CAGR in the cardiac imaging software market over the discussed timeframe. On account of developing economic conditions, a rise in healthcare expenses and infrastructural investments has been noticed across the region. A quantitative survey conducted by Novartis in 2021 concluded that this region is expected to capture 40.0% of the net growth in global healthcare spending over the next decade. Additionally, developing countries such as Japan, China, and India are becoming prime marketplaces for global pioneers in this category due to demand inflation and technological propagation. For instance, in October 2023, Chiba Institute of Technology partnered with the Icahn School of Medicine at Mount Sinai to accelerate AI-based innovations in cardiac imaging.
The magnifying burden of sudden cardiovascular events, such as stroke and ischemic heart diseases, in India presents a demanding consumer base for the cardiac imaging software market. In addition, rapid urbanization, sedentary lifestyles, and hypertension are contributing to the heightening mortality of CVD, whose annual death case count was estimated at 4.7 million in 2020. The emphasizing demography is further attracting foreign forces to establish their line of business in this landscape. For instance, in October 2023, Abbott unraveled the potential of its intravascular imaging tool, Ultreon 1.0 Software, in India. The new vascular imaging platform is powered by a combination of optical coherence tomography and AI, allowing automated operations and outcome optimization.
Key Cardiac Imaging Software Market Players:
- Siemens Healthcare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Toshiba
- GE Healthcare
- Philips Healthcare
- Epsilon Imaging
- Shimadzu Corporation
- Circle Cardiovascular Imaging Inc.
- CardioComm Solutions Inc.
- Integer Holdings Corporation
- McKesson Corporation
- Exo Healthcare
The cardiac imaging software market is evolving with the ongoing technological upgrades in existing pipelines. Key players in this merchandise are leveraging their pace of development to solidify their global presence and portfolio. They are also focusing on attaining maximum regulatory compliance for seamless globalization. For instance, in August 2024, GE Healthcare gained CE marks for its Vscan Air SL wireless handheld ultrasound system with Caption AI from the European Union. Further, in the month of September, the company displayed both the Revolution Apex platform and Vscan Air SL at the European Society of Cardiology (ESC) Congress in London. Such commercial expansion is influencing other competitors to bring new products into the market. This cohort of pioneers includes:
Recent Developments
- In April 2025, Exo received FDA 510(k) clearance for adding Global Longitudinal Strain (GLS) analysis abilities to its Exo Iris ultrasound device. This SweepAI-based GLS auto-quantification feature is intended to serve clinicians with instant, bedside cardiac insights for faster and precise diagnosis of heart failure and cardiotoxicity.
- In March 2025, GE Healthcare introduced a new CT system, Revolution Vibe, with unlimited one-beat cardiac imaging. It is backed by the company's revolutionary AI-powered solutions, including ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless Workflow, to deliver a fast, comfortable, and accurate diagnosis.
- In February 2025, Philips strengthened its MRI portfolio through the launch of a new AI-powered MRI acceleration software, SmartSpeed Precise, at the 2025 European Congress of Radiology (ECR). This next-generation solution is powered by dual-AI engines to offer faster scans and higher image quality.
- Report ID: 1331
- Published Date: Jun 13, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Cardiac Imaging Software Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
